Rain Oncology Inc. Proceeds from Stock Options Exercised
Rain Oncology Inc. reported Proceeds from Stock Options Exercised of $121.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2022-03-03
- Rain Oncology Inc. proceeds from stock options exercised for the quarter ending 2021-12-31 was $36.00K, a 25.00% decline year-over-year.
- Rain Oncology Inc. proceeds from stock options exercised for the quarter ending 2021-09-30 was $0.00.
- Rain Oncology Inc. proceeds from stock options exercised for the quarter ending 2020-12-31 was $48.00K.
- Rain Oncology Inc. proceeds from stock options exercised for fiscal 2021 was $121.00K, a 152.08% increase from fiscal 2020.
- Rain Oncology Inc. proceeds from stock options exercised for fiscal 2020 was $48.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2021-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $36.00K derived: sum of 2 quarters · filed 2022-03-03 | $121.00K 10-K · filed 2022-03-03 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $85.00K 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $85.00K 10-Q · filed 2021-08-10 | |||
| 2020-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $48.00K 10-K · filed 2022-03-03 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 |